Regulations
Samsung BioLogics boost to cell line dev with patent win over Lonza
RegulationsSamsung BioLogics boost to cell line dev with patent win over LonzaSamsung BioLogics boost to cell line dev with patent win over Lonza
Lonza is “clearly disappointed” after the IP Tribunal in Korea ruled in favor of Samsung BioLogics in invalidating a patent